Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 26, 2017

Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 16, 2020

    W.Va. Ax Of Biogen MS Drug Patent Binds Del. Litigation

    A Delaware federal judge on Wednesday said she's bound by a June decision from West Virginia invalidating a patent covering Biogen's blockbuster multiple sclerosis drug Tecfidera, even though she presided over a trial on the patent's validity in December.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login